Abeona Therapeutics (ABEO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to 0.74.
- Abeona Therapeutics' Equity Ratio rose 9521.18% to 0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74, marking a year-over-year increase of 9521.18%. This contributed to the annual value of 0.4 for FY2024, which is 7449.24% up from last year.
- Abeona Therapeutics' Equity Ratio amounted to 0.74 in Q3 2025, which was up 9521.18% from 0.66 recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Equity Ratio ranged from a high of 0.74 in Q3 2025 and a low of 0.12 during Q1 2024
- In the last 5 years, Abeona Therapeutics' Equity Ratio had a median value of 0.4 in 2024 and averaged 0.42.
- Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 13378.48% in 2024, then soared by 45101.98% in 2025.
- Over the past 5 years, Abeona Therapeutics' Equity Ratio (Quarter) stood at 0.53 in 2021, then decreased by 21.72% to 0.42 in 2022, then crashed by 44.41% to 0.23 in 2023, then surged by 74.49% to 0.4 in 2024, then skyrocketed by 83.31% to 0.74 in 2025.
- Its Equity Ratio stands at 0.74 for Q3 2025, versus 0.66 for Q2 2025 and 0.42 for Q1 2025.